WNV (West Nile Virus) test to quell health officials' concerns:
This article was originally published in Clinica
Executive Summary
The availability of an assay for West Nile Virus, an RNA flavivirus spread by mosquitoes among mammals, could do much to quell concerns over the growing problem and spread of the virus. Data from the US Centers for Disease Control and Prevention (CDC) show that the virus, which causes meningoencephalitis, inflaming the spinal cord and brain, killed seven people among 62 recorded cases in 1999. It has struck in temperate North American and European zones, threatening public and animal health. The new virus assay, from American Medical Laboratories, of Chantilly, Virginia, is done by realtime PCR, said to be the most rapid and sensitive methodology available.
You may also be interested in...
Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time
Small sterilizers told Medtech Insight that they were ready for the EPA’s controversial EtO emissions rule, while community advocates expressed concerns.
Day One Springs Into Commercial Action With Ojemda Approval
The company is targeting around 200 centers that treat the vast majority of the few thousand pediatric low-grade glioma patients who are candidates for the RAF-targeting drug.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.